All articles tagged with #glucose monitors
The FDA warns that some Abbott FreeStyle Libre 3 and 3 Plus glucose sensors may provide incorrect low readings due to a manufacturing issue, linked to hundreds of adverse events and seven deaths outside the U.S. Patients are advised to stop using affected devices and seek replacements, as the issue has been identified and resolved.
Continuous glucose monitors, originally for diabetics, are now used by health enthusiasts to track blood sugar in real time, helping them make dietary and lifestyle adjustments that could support weight management and overall health.
Continuous glucose monitors are not a comprehensive solution for public health issues related to diabetes, highlighting the need for broader strategies beyond just technological advancements.
Non-diabetic individuals are increasingly using glucose monitors as a tool to improve their overall health, with devices like the Lingo sensor providing real-time blood glucose data to smartphones. These monitors, which also offer lifestyle tips, are seen as a way to prevent conditions like type 2 diabetes and dementia. However, there are concerns about their accuracy compared to traditional methods and the potential for users to overlook other health markers. Despite these concerns, the popularity of such devices is growing, with companies like Zoe and Abbott's Lingo reporting significant user numbers and waitlists.
Abbott has recalled its FreeStyle Libre Glucose Monitors due to the risk of extreme heat and fire. The recall has been identified as Class 1 by the FDA. The devices were intended to provide continuous monitoring of glucose levels for people managing diabetes. The recall was issued due to the reader devices used to recharge lithium-ion batteries, which may get extremely hot, spark, or catch on fire if not appropriately stored, charged, or used with its Abbott-provided USB cable and power adapter. The FDA recommends that users stop using the devices and switch to a backup method. Abbott's customer service can be contacted for replacement USB cables or power adapters.
Abbott has issued a warning impacting four million readers for glucose monitors after reports that devices were overheating and catching fire when patients used non-Abbott charging cords. The FDA identified the problem as a Class 1 recall, which signals that use of a device might cause serious injury. The warning includes readers for several different models of Abbott’s FreeStyle Libre glucose monitors, which help people with diabetes monitor their blood glucose levels regularly without finger pricks. Abbott reported 206 incidents of the device malfunction, including at least seven fires and one injury.